In vivo experiments on mouse model confirmed that growth factors in healing wounds may promote tumor growth, affecting therapeutic effect of immunotherapy with interleukin-2 (IL-2) and lympokine activated killer (LAK) cells [45, 46]. This evidence concerns the gene IL2 and neoplasm.